C12N 2730/10144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2730/10144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 3
- Inventors
- 7
- Latest grant
- 27 Dec 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 3 |
| 2021 | 2 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
- Hepatitis B nanoparticle-based vaccine for influenza virus27 Dec 2022US 11,535,651 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof24 Aug 2021US 11,098,123 B2Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd
- Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof2 Mar 2021US 10,934,357 B2Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd
- Hepatitis b nanoparticle-based vaccine for influenza virus26 Nov 2020US 2020/0369730 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Malignant glioma car-t therapeutic vector based on octs technology, and construction method and application thereof11 Jun 2020US 2020/0181268 A1Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd
- Octs technology-based pancreatic cancer and malignant mesothelioma car-t therapeutic vector, construction method therefor, and use thereof11 Jun 2020US 2020/0181269 A1Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.